Viking Therapeutics, Inc

VKTXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
28.45 USD
↘ 1.33 (4.47%)AT CLOSE (11:59 AM EDT)
28.62
↗ 0.17 (0.59%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
28.62
↗ 0.17 (0.59%)
🔴Market: CLOSED
Open?$29.57
High?$29.81
Low?$28.04
Prev. Close?$29.78
Volume?2.7M
Avg. Volume?2.2M
VWAP?$28.76
Rel. Volume?1.27x
Bid / Ask
Bid?$28.45 × 100
Ask?$28.79 × 200
Spread?$0.34
Midpoint?$28.62
Valuation & Ratios
Market Cap?3.3B
Shares Out?116.1M
Float?111.8M
Float %?96.8%
P/E Ratio?N/A
P/B Ratio?6.58
EPS?-$4.07
Dividend?0.00%
Ex-Dividend?N/A

Shares of Viking Therapeutics, Inc (VKTX) are trading at $28.45. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place VKTX at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

RelatedLLYMDGLPFE
News
Profile
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Themes
Biotech - Drug Development›Metabolic & Cardiometabolic
Employees
59
Market Cap
3.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.vikingtherapeutics.com
Listed
2015-04-29
Address
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO, CA 92121
Phone: 858-704-4660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
39
Piotroski F-Score?0/9Weak
Altman Z-Score?14.59Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?19.92%High
Short Interest?22.3M
Days to Cover?11.2
Free Float111.8M
Avg Daily Volume2.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?5.72Strong
Quick Ratio?5.72Strong
Cash Ratio?1.11Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
75
S&P
28
6.58FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-6.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
33
S&P
3
-94.1%WEAK▾
ROA?
Peers
33
S&P
3
-77.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist